Lactalis International agreed to buy an infant-formula business from Aspen Pharmacare Holdings Ltd for 739.8 million euros ($860 million) as the French dairy group targets the fast-growing Chinese market.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
